BML Capital Management’s ImageneBio Inc IMA Stock Holding History

BML Capital Management’s Portfolio IMA Stock Details IMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.18M	Hold	200,730	–	–	0.67%	15
2026 Q1	$1M	Buy	200,730 +23,704	+13%	+$154K	0.64%	15
2025 Q4	$1.22M	Sell	177,026 -5,483	-3%	-$40.7K	1.06%	12
2025 Q3	$1.49M	Sell	182,509 -153,333	-46%	-$2.03M	1.36%	11
2025 Q2	$5.4M	Buy	335,842 +26,608	+9%	+$391K	4.09%	8
2025 Q1	$4.75M	Buy	309,234 +10,412	+3%	+$180K	3.84%	9
2024 Q4	$5.88M	Buy	298,822 +238,548	+396%	+$4.82M	3.65%	10
2024 Q3	$1.25M	Buy	60,274 +11,514	+24%	+$233K	0.74%	18
2024 Q2	$965K	Buy	+48,760	New	+$861K	0.69%	21

Other funds holding IMA

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MIM

Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BML Capital Management's IMA Position: Q2 2026 in Review

BML Capital Management held its ImageneBio Inc (IMA) position steady in Q2 2026 at 200,730 shares worth $1.18M. The position accounts for 0.67% of the portfolio, ranked #15.

BML Capital Management first reported a position in IMA in Q2 2024 and has held it in 9 quarters since. The position peaked at $5.88M in Q4 2024. 17 funds tracked by Wall St. Rank hold IMA as of Q2 2026.

BML Capital Management held 200,730 shares of ImageneBio Inc worth $1.18M as of Q2 2026.
BML Capital Management left its ImageneBio Inc share count unchanged in Q2 2026.
ImageneBio Inc made up 0.67% of BML Capital Management's portfolio in Q2 2026, its #15 holding.
BML Capital Management first reported a position in ImageneBio Inc in Q2 2024 and has held it in 9 quarters since.
BML Capital Management's ImageneBio Inc position peaked at $5.88M in Q4 2024.
17 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2026.

Based on BML Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.